Portfolio Bar

BioProcess International Conference & Exposition

BPI Is Engineered to Be Exactly What You Need It to Be…

Register Now and Save 800

Conference: October 04-07, 2016 * Exposition:  October 5-07, 2016 * Boston Convention and Exhibition Center, Boston, MA

navigation

Alt Language

Alternative Language Options:

  • Japanese
  • Korean
  • Taiwanese
  • Chinese
  • English

THE Industry Meeting Place to Exchange Real-World Solutions to Improve Speed, Cost and Quality

Conference: October 04-07, 2016 · Exhibition: October 17-19, 2016 · Boston Convention and Exhibition Center · Boston, MA

Manufacturing Strategy

Manufacturing Strategy

Manufacturing Strategy Preliminary Agenda

  • Manufacturing optimization and process intensification
  • Manufacturing case studies of complex, novel and niche molecules
  • Facilities of the future - adapting new or legacy facilities to be more flexible
  • Manufacturing for late stage development and commercial products

Wednesday-Friday, October 5-7, 2016

Bioreactor Process Improvements in a Legacy Perfusion-based Process
Jiayi Zhang, Ph.D., Manager Process Engineering Development, MSAT, Genzyme

Controlling Raw Material Variability Improves the Biopharmaceutical Process Consistency and Product Quality
Nandu Deorkar, Ph.D., Vice President, Research and Development, Avantor Performance Materials

Building the Foundations for Excellence in Biopharmaceutical Raw Material Supply Chains
Prateek Gadhoke, Associate Director, Bioprocess Materials, Bristol-Myers Squibb

Evaluating Risk of Components in Aging Facilities
Christopher Smalley, Ph.D., Director, Engineering, Global Technical Operations, Merck & Co.

DOE and Predictive Modeling to Improve Decisions on the Manufacturing Floor
Martin Kane, Managing Data Scientist, Exponent

Maximizing the Value of Commercial Scale Data: A Case Study
Tom Mistretta, Principal Engineer, Process Development, Amgen, Inc.

Modelling Single-use Mixing Systems
Suresh Nulu, Scientist, Biogen

Innovative Strategies Optimizing Capacity and Flexibility in the Amgen, RI Biomanufacturing Plant
Jessica Morse, Senior Manager Cell Culture, Amgen

Experimental Data Supporting Risk-Based Biopharmaceutical Facility Design Approaches
Jeffrey Johnson, New Technology Lead and Director, Center for BioManufacturing Sciences, Merck & Co., Inc.

BPOG Leachables Best Practice Testing Guide for Industry
Seamus O'Connor, Ph.D., Manager Chemistry Method Development, Analytical Sciences, Industrial Operations and Product Supply, Regeneron Pharmaceuticals, Inc.
Ping Wang, Ph.D., Principal Scientist, Materials Sciences, Pharmaceutical Development and Manufacturing Sciences, Janssen Research & Development

Changing the Performance Paradigm in BioPharma: Integrating Human Performance in Global Operations
Amy Wilson, Ph.D., Director, Performance Development, Global Biologics Manufacturing & Technical Operations, Biogen
Michael Moedler, Ph.D., Head Error Prevention System, Lonza AG, Switzerland

Harmonization of Room Classification and Gowning Requirements across the Biopharmaceutical Manufacturing Industry
Lars Hovmand-Lyster, M.D., Principal Scientist Recovery, Diabetes Active Pharmaceutical Ingredients, Novo Nordisk, Denmark

Footprinting our Drugs: Biologics Process Mass Intensity Tool
Bonnie Shum, Engineer, Global Biologics Manufacturing Sciences and Technology, Genentech, Inc., A Member of the Roche Group

Enabling Flexibility through Automation for a New Manufacturing Facility
Ryan Hogan, Scientist I, Manufacturing Sciences and Technology, AstraZeneca

Protecting the Patient through Enhanced Supply Chain Security
Rob Welsh, Vice President, Bioprocessing Segment Solutions, VWR and Rx-360 International Pharmaceutical Supply Chain Consortium Board Member & Co-Chair of Supply Chain Security

Post Commercial Process Monitoring Strategies and Case Studies
Syama Adhibhatta, Scientist, Bristol-Myers Squibb

Manufacturing for Late Phase Development
Speaker TBA, FUJIFILM Diosynth Biotechnologies

Featured Session: Industry-Academia Collaborations in Translational Research and Biomanufacturing of Next-Generation Biologics
Kamal Rashid, Ph.D. Director, Biomanufacturing Education & Training Center and Research Professor of Biology/Biotechnology, Worcester Polytechnic Institute
Mark S. Klempner, M.D., Executive Vice Chancellor, Mass Biologics and Professor of Medicine, University of Massachusetts Medical School
Susan Roberts, Ph.D. Professor and Head, Chemical Engineering Department, Worcester Polytechnic Institute
Stacy Springs, Ph.D. Director, Biomanufacturing Program, Executive Director, Consortium on Adventitious Agent Contamination in Biomanufacturing, MIT Center for Biomedical Innovation
Jerome Ritz, M.D., Executive Director, Connell O'Reilly Manipulation Core Facility and Professor of Medicine, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School
David Dismuke, Ph.D. Director of Vector Production, Voyager Therapeutics Inc.

footer